z-logo
Premium
Pathobiologic Mechanisms of Neurodegeneration in Osteopetrosis Derived From Structural and Functional Analysis of 14 ClC ‐7 Mutants
Author(s) -
Di Zanni Eleonora,
Palagano Eleonora,
Lagostena Laura,
Strina Dario,
Rehman Asma,
Abinun Mario,
De Somer Lien,
Martire Baldassarre,
Brown Justin,
Kariminejad Ariana,
Balasubramaniam Shanti,
Baynam Gareth,
Gurrieri Fiorella,
Pisanti Maria A,
De Maggio Ilaria,
Abboud Miguel R,
Chiesa Robert,
Burren Christine P,
Villa Anna,
Sobacchi Cristina,
Picollo Alessandra
Publication year - 2021
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1002/jbmr.4200
Subject(s) - osteopetrosis , neurodegeneration , mutant , microbiology and biotechnology , mutation , biology , chemistry , gene , biochemistry , medicine , pathology , immunology , disease
ClC‐7 is a chloride‐proton antiporter of the CLC protein family. In complex with its accessory protein Ostm‐1, ClC‐7 localizes to lysosomes and to the osteoclasts' ruffled border, where it plays a critical role in acidifying the resorption lacuna during bone resorption. Gene inactivation in mice causes severe osteopetrosis, neurodegeneration, and lysosomal storage disease. Mutations in the human CLCN7 gene are associated with diverse forms of osteopetrosis. The functional evaluation of ClC‐7 variants might be informative with respect to their pathogenicity, but the cellular localization of the protein hampers this analysis. Here we investigated the functional effects of 13 CLCN7 mutations identified in 13 new patients with severe or mild osteopetrosis and a known ADO2 mutation. We mapped the mutated amino acid residues in the homology model of ClC‐7 protein, assessed the lysosomal colocalization of ClC‐7 mutants and Ostm1 through confocal microscopy, and performed patch‐clamp recordings on plasma‐membrane‐targeted mutant ClC‐7. Finally, we analyzed these results together with the patients' clinical features and suggested a correlation between the lack of ClC‐7/Ostm1 in lysosomes and severe neurodegeneration. © 2020 American Society for Bone and Mineral Research (ASBMR).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here